![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Leiden/Amsterdam Center for Drug Research, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (H.D.L., R.M.v.R., R.A.B., R.L.); and Johnson & Johnson Pharmaceutical Research & Development, L.L.C., San Diego, California (P.L., R.L.T.)
The histamine H4 receptor (H4R) is involved in the chemotaxis of leukocytes and mast cells to sites of inflammation and is suggested to be a potential drug target for asthma and allergy. So far, selective H4R agonists have not been identified. In the present study, we therefore evaluated the human H4R (hH4R) for its interaction with various known histaminergic ligands. Almost all of the tested H1R and H2R antagonists, including several important therapeutics, displaced less than 30% of specific [3H]histamine binding to the hH4R at concentrations up to 10 µM. Most of the tested H2R agonists and imidazole-based H3R ligands show micromolar-to-nanomolar range hH4R affinity, and these ligands exert different intrinsic hH4R activities, ranging from full agonists to inverse agonists. Interestingly, we identified 4-methylhistamine as a high-affinity H4R ligand (Ki = 50 nM) that has a >100-fold selectivity for the hH4R over the other histamine receptor subtypes. Moreover, 4-methylhistamine potently activated the hH4R (pEC50 = 7.4 ± 0.1;
= 1), and this response was competitively antagonized by the selective H4R antagonist JNJ 7777120 [1-[(5-chloro-1H-indol-2-yl)-carbonyl]-4-methylpiperazine] (pA2 = 7.8). The identification of 4-methylhistamine as a potent H4R agonist is of major importance for future studies to unravel the physiological roles of the H4R.
Address correspondence to: Dr. R. Leurs, Leiden/Amsterdam Center for Drug Research, Department of Medicinal Chemistry, Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands. E-mail: r.leurs{at}few.vu.nl
This article has been cited by other articles:
![]() |
H. Francis, S. Glaser, S. DeMorrow, E. Gaudio, Y. Ueno, J. Venter, D. Dostal, P. Onori, A. Franchitto, M. Marzioni, et al. Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway Am J Physiol Cell Physiol, August 1, 2008; 295(2): C499 - C513. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Haas, O. A. Sergeeva, and O. Selbach Histamine in the Nervous System Physiol Rev, July 1, 2008; 88(3): 1183 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Pos, Z. Wiener, P. Pocza, M. Racz, S. Toth, Z. Darvas, V. Molnar, H. Hegyesi, and A. Falus Histamine Suppresses Fibulin-5 and Insulin-like Growth Factor-II Receptor Expression in Melanoma Cancer Res., March 15, 2008; 68(6): 1997 - 2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kool, A. Van Marle, S. Hulscher, M. Selman, D. J. Van Iperen, K. Van Altena, M. Gillard, R. A. Bakker, H. Irth, R. Leurs, et al. A Flow-Through Fluorescence Polarization Detection System for Measuring GPCR-Mediated Modulation of cAMP Production J Biomol Screen, December 1, 2007; 12(8): 1074 - 1083. [Abstract] [PDF] |
||||
![]() |
E. Breunig, K. Michel, F. Zeller, S. Seidl, C. W. H. v. Weyhern, and M. Schemann Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors J. Physiol., September 1, 2007; 583(2): 731 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Morgan, B. McAllister, L. Cross, D. S. Green, H. Kornfeld, D. M. Center, and W. W. Cruikshank Histamine 4 Receptor Activation Induces Recruitment of FoxP3+ T Cells and Inhibits Allergic Asthma in a Murine Model J. Immunol., June 15, 2007; 178(12): 8081 - 8089. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. van Rijn, P. L. Chazot, F. C. Shenton, K. Sansuk, R. A. Bakker, and R. Leurs Oligomerization of Recombinant and Endogenously Expressed Human Histamine H4 Receptors Mol. Pharmacol., August 1, 2006; 70(2): 604 - 615. [Abstract] [Full Text] [PDF] |
||||